SLEAFORD MEDICAL GROUP
BOSTON ROAD, SLEAFORD
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 136 | 160 | 85.0% | |
| CKD 4 | 2008 | 268 | 310 | 86.5% | |
| CKD 5 | 2009 | 135 | 164 | 82.3% | |
| CKD 5 | 2010 | 30 | 36 | 83.3% | |
| CKD 5 | 2011 | 38 | 47 | 80.9% | |
| CKD 5 | 2012 | 40 | 49 | 81.6% | |
| CKD 5 | 2013 | 36 | 43 | 83.7% | |
| CKD003 | 2014 | 37 | 41 | 90.2% | |
| CKD003 | 2015 | 42 | 46 | 91.3% | |
| NM84 | 2016 | 36 | 50 | 72.0% | |
| NM84 | 2017 | 39 | 53 | 73.6% | |
| NM84 | 2019 | 38 | 60 | 63.3% | |
| NM84 | 2020 | 35 | 64 | 54.7% | |
| NM84 | 2022 | 37 | 51 | 72.5% |
